| 1 | Energy | XLE | +50.0% |
| 2 | Technology | XLK | +31.5% |
| 3 | Healthcare | XLV | +16.5% |
| 4 | Consumer Staples | XLP | +11.9% |
| 5 | Materials | XLB | +11.5% |
| 6 | Industrials | XLI | +6.0% |
| 7 | Real Estate | XLRE | +3.9% |
| 8 | Financials | XLF | +1.9% |
| 9 | Utilities | XLU | -0.9% |
| 10 | Consumer Disc. | XLY | -2.9% |
| 11 | Communication | XLC | -12.0% |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/5/26 | $2.31 | — | — | — | $0.5B | — | — | — |
| Q2 '26 | 8/6/26 | $1.80 | $2.28 | +26.7% | +48% | $0.4B | $0.5B | +18.7% | +48% |
| Q1 '26 | 5/11/26 | $1.51 | $1.60 | +6.0% | +44% | $0.4B | $0.4B | +5.0% | +42% |
| Q4 '25 | 2/17/26 | $2.15 | $-0.24 | -1.1% | -119% | $0.4B | $0.5B | +1.0% | +52% |
| Q3 '25 | 11/3/25 | $1.58 | $1.72 | +8.9% | +35% | $0.3B | $0.4B | +4.7% | +22% |
| Q2 '25 | 8/5/25 | $1.20 | $1.54 | +28.3% | +69% | $0.3B | $0.3B | +13.9% | +41% |
| Q1 '25 | 5/6/25 | $0.94 | $1.11 | +18.1% | +41% | $0.2B | $0.3B | +15.1% | +35% |